Effect of Consuming a Mango and Chia-based Beverage on Modulating the Intestinal Microbiota in Obese Children

ConditionMicrobiota
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-16
SponsorUniversidad Nacional de Caaguazu

About this trial

This randomized clinical trial evaluates the effect of a mango and chia-based beverage on gut microbiota modulation in 100 Paraguayan children aged 8-16 years with obesity. Participants will consume the intervention beverage for 6 weeks. Fecal samples will be collected before and after each intervention to analyze microbiota composition using 16S rRNA sequencing. This study aims to characterize the gut microbiota of Paraguayan children for the first time and assess whether this functional beverage can positively modulate intestinal bacteria as a potential strategy to address childhood obesity, which affects 1 in 3 school-age children in Paraguay.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mango juice

    Other intervention

    Mango juice drink for 6 weeks 200 ml daily, 5 days a week

  • Mango and chia juice

    Other intervention

    Mango and chia juice drink for 6 weeks, 200 ml daily 5 days a week

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Mango berverageExperimental treatment 1 intervention
Group B: Mango and chia berverageActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Microbiota

Gut microbiota composition analysis (16S rRNA sequencing)

Time frame
Baseline and after 4 weeks

Secondary outcomes

1

Anthropometric measurements

Measure of weight

Time frame
Baseline and after 4 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.